Table 2.
Total estimated vaccine volume (doses in million) in five years period of dengue vaccine introduction by different vaccination schedules and options
Option 1 | Option 2 | Option 3 | Option 4 | |
Only EPI (1–2 years) | EPI (1–2 yrs) + Age 1–14 yrs Cohort | EPI (1–2 yrs) + Age 1–39 year cohort | EPI (1–2 yrs) + All ages (>1 yrs) | |
All country | ||||
Single dose schedule | 17.8–21.3 | 54.8–65.6 | 128.6–154.1 | 186.6–228.0 |
Two dose schedule | 34.9–41.9 | 115.0–137.8 | 250.8–300.6 | 346.9–415.7 |
Three dose schedule | 52.6–62.9 | 194.3–202.6 | 354.8–425.1 | 493.2–590.9 |
Selected Regions* | ||||
Single dose schedule | 49.5–59.3 | 108.4–133.3 | 157.7–192.4 | |
Two dose schedule | 103.7–124.2 | 212.1–254.1 | 301.4–361.1 | |
Three dose schedule | 152.5–182.7 | 300.9–360.6 | 421.0–504.5 |
Note: Ranges are for 10% and 25% vaccine wastage assumptions. Option 1, EPI only; Option 2, EPI+ 1–14 yrs cohort mass vaccination; Option 3, EPI + 1–39 yrs mass vaccination; Option 4, EPI+ >1 yrs all age groups. EPI, Country 1–2 age cohort for 5 years routine vaccination; Mass vaccination, one-time during 5 years.